Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.

Translated title of the contribution: Paclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.

G.S. Sonke, I.A. Mandjes, M.J. Holtkamp, M. Schot, E. van Werkhoven, J. Wesseling, M.J. Vrancken Peeters, S. Rodenhuis, S.C. Linn

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionPaclitaxel, carboplatin, and trastuzumab in a neo-adjuvant regimen for HER2-positive breast cancer.
Original languageUndefined/Unknown
Pages (from-to)419-426
Number of pages8
JournalThe Breast Journal
Volume19
Issue number4
Publication statusPublished - 2013

Cite this